Publications, 2002

Department of Oncology, LundUniversityHospital, Lund

  1. Amini R-M, Glimelius B, Gustavsson A, Ekman T, Erlanson M, Haapaniemi E, and Enblad G: A population-based study of the outcome for patients with first relapse of Hodgkin´s lymphoma. Eur J Haematol 2002; 68:225-232.
  1. Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, Tennvall-Nittby L, Pettersson-Sköld D, Sverrisdottir A, Söderberg M, Klaar S, and Bergh J: A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (HerceptinR) on a named patient basis in Sweden. Acta Oncol 2002; 41 (3):276-281.
  1. Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Conati D, Manfrini M, Lari S, Briccoli A, and Forni C: High dose Ifosfamide in combination with high dose Methotrexate, Adriamycin and Cisplatin in the neoadjuvant treatment of extremity osteosarcoma: Preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Pilot Study. J Chemother 2002; 14(2):198-206.
  1. Brun E, Kjellén E, Tennvall J, Ohlsson T, Sandell A, Perfekt R, Wennerberg J, and Strand S-E. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head and Neck 2002; 24:127-135.
  1. Dreinhöfer K, Baldetorp B, Åkerman M, Fernö M, Rydholm A, and Gustafson P: DNA ploidy in soft tissue sarcoma: Comparison of flow and image cytometry with clinical follow-up in 93 patients. Cytometry 2002; 50(1):19-24.
  1. Elit L, Pal T, Goshen R, Jernström H, Ackerman I, Fyles A, Carey M, Mitchell M, Aube J, and Narod SA: Familial and hormonal risk factors for papillary serous uterine cancer. Eur J Gynaec Oncol 2002; 3:187-190.
  1. Enblad G, Gustavsson A, Sundström C, and Glimelius B, for the Swedish Lymphoma Study Group: Patients above sixty years of age with Hodgkin´s lymphoma treated with

a new strategy. Acta Oncol 2002; 41 (7/8):659-667.

  1. Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenter C, Martino R, Dekker AW, Prentice HG, Gustavsson A, and Ljungman P: Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Hematol 2002; 117:444-450.
  1. Fernebro E, Dictor M, Bendahl P-O, Fernö M, and Nilbert M: Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med 2002; 126:702-705.
  1. Fernebro E, Halvarsson B, Baldetorp B, and Nilbert M: Predominance of CIN versus

MSI in the development of rectal cancer at young age. BMC Cancer 2002; 2:25:1-8.

  1. Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjövall M, Fornander T, Holmqvist M, Holmberg L, and Frisell J: Consequences of axillary recurrence after conservative breast surgery. Br J Surgery 2002; 89:902-908.
  1. Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjövall M, Fornander T, Holmqvist M, Holmberg L, and Frisell J: Local recurrence in the breast after conser-vative surgery – a study of prognosis and prognostic factors in 391 women. Eur J

Cancer 2002; 38(14): 1860-1870.

  1. Gruvberger S, Ringnér M, Edén P, Borg Å, Fernö M, Peterson C, and Meltzer P: Expression profiling to predict outcome in breast cancer: the influence of sample selection. Breast Cancer Res 2002; 5(1):23-26.
  1. Hardell L, Eriksson M, and Nordström M: Exposure to pesticides as risk factor for Non-Hodgkin´s lymphoma and hairy cell leukemia: Pooled analysis of two Swedish case-control studies. Leukemia and Lymphoma 2002; 43(5): 1043-1049.
  1. Hindorf C, Lindén O, Tennvall J, Wingårdh K, and Strand S-E: Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry. Cancer 2002; 94:1235-1239.
  1. Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E, Pendergast W, Möller S, Edvinsson L, and Erlinge D: UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol 2002; 282 (2):784-792.
  1. Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F, and Nilbert M: Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition. Cancer Res 2002; 62:5939-5946.
  1. Jerkeman M, Åman P, Cavallin-Ståhl E, Torlakovic E, Åkerman M, Mitelman F, and Fioretos T: Prognostic implications of BCL6 rearrangemant in uniformly treated patients with diffuse large B-cell lymphoma – a Nordic Lymphoma Group Study. Int J Oncol 2002; 20 (1):161-165.
  1. Johansson T, Soto Thompson M, Stenberg M, af Klinteberg C, Andersson-Engels S, Svanberg S, and Svanberg K: Feasibility study of a novel system for combined light dosimetry and interstitial photodynamic treatment of massive tumors. Applied Optics 2002; 41 (7):1462-1468.
  1. Jönsson M, Dejmek J, Bendahl P-O, and Andersson T: Loss of wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 2002; 62(2):409-416.
  1. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, Guénel P, Hardell L, Cyr D, Ballard T, Zambon P, Morales Suárez-Varela MM, Stang A, and Olsen J: Occupational risk factors for small bowel carcinoid tumor: A European population-based case-control study. J Occup Environ Med 2002; 44:516-522.
  1. Kinhult S, Eskilsson J, Albertsson M, and Cwikiel M: Endothelial damage after treatment with low-molecular weight heparins – a morphological study. Scand Cardiovasc J. In press.
  1. Koul A, Willén R, Bendahl P-O, Nilbert M, and Borg Å: Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 2002; 94: 2369-2379.
  1. Koul A, Bendahl P-O, Borg Å, Fernö M, Lidebring MF, Högberg T, Einarsson EL., Ridderheim M, and Willén R: TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer. Int J Gynecol Cancer 2002; 12:362-371.
  1. Lindén O, Hindorf C, Tennvall J, Segren S, Wingårdh K, and Strand S-E: Single tumor cell uptake and dosimetry of Technetium-99m Fab´anti-CD22 in low-grade B-cell lymphoma. Cancer 2002; 94/4:1270-1274.
  1. Lindén O, Tennvall J, Hindorf C, Cavallin-Ståhl E, Lindner K-J, Ohlsson T, Wingårdh K, and Strand S-E: 131l-labelled Anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates. Acta Oncol 2002; 41(3):297-303.
  1. Lindén O: Radioimmunotherapy of B-cell lymphoma. Clinical studies with anti-CD22 antibodies. Lund University 2002. 06-07-2002 PhD. Dr in Medical Science.
  1. Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdalenat H, Brunner N, Duggan C, Lisboa BW, Bendahl P-O, Quillien W, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broet P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O´Higgins N, Eppenberger U, Janicke F, Schmitt M, and Foekens JA: Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 2002; 94(2):116-128.
  1. Luoma M-L, Hakamies-Blomqvist L, Sjöström J, Mouridsen H, Pluzanska A, Malmström P-O, Bengtsson N-O, Hultborn R, Östenstad B, Mjaaland I, Valvere V, Wist E, Baldursson G, Ahlgren J, and Blomqvist C. Physical performance, toxicity and quality of life as assessed by the physician and the patient. Acta Oncol 2002; 41:44-49.
  2. Mandahl N, Gustafson P, Mertens F, Åkerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HCF, and Larsson O: Cytogenetic abberations and their prognostic impact in chondrosarcoma. Genes, Chromosomes & Cancer 2002; 33:188-200.
  3. Narod S, Dubé M-P, Klijn J, Lubinski J, Lynch H, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber J, Neuhausen S, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes W, Warner E, Kim-Sing C, Olopade O, Tung N, Saal H, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, and Brunet
  4. J-S: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J of the National Cancer Institute 2002; 94 (23):1773-1779.
  1. Nilbert M, and Planck M: Mismatch-repair deficiency in the development of tumor types associated with Hereditary Nonpolyposis Colorectal Cancer. Recent Research Developments in Cancer 2002; 4:395-418.
  1. Nilbert M, and Coffin CM: Gardner syndrome. In: Pathology & Genetics; tumors of soft tissue and bone. WHO 2002; 352-354.
  1. Nilbert M, Grönberg H, and Lindblom A: Hereditary nonpolyposis colorectal cancer – an update. Läkartidningen 2002; 34:3296-300.
  1. Nordengren J, Fredstorp-Lidebring M, Bendahl P-O, Brunner N, Fernö M, Högberg T, Stephen RW, Willén R, and Casslén B: High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. Int J Cancer 2002; 97(3):379-385.
  2. Olsson H, Bladstrom A. A cohort study of reproductive factors and family history of breast cancer in southern Sweden.Breast Cancer Res Treat. 2002 Dec;76(3):203-209.
  3. Wirfalt E, Mattisson I, Gullberg B, Johansson U, Olsson H, Berglund G.Postmenopausal breast cancer is associated with high intakes of omega6 fatty acids (Sweden).Cancer Causes Control. 2002 Dec;13(10):883-893
  4. Planck M, Halvarsson B, Pålsson E, Hallén M, Ekelund M, Pålsson B, Baldetorp B, and Nilbert M: Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in an HNPCC colon carcinoma. Cancer Genet and Cytogenet 2002; 134:46-54.
  1. Planck M, Rambech E, Möslein Gm, Muller W, Olsson H, and Nilbert M: High frequency of microsatellite instability and loss of mismatch-repair protein expression in double primary cancers of the endometrium and colorectum. Cancer 2002; 94:2502-2510.
  1. Relander T, Karlsson S, and Richter J: Oncoretroviral gene transfer to NOD/SCID repopulating cells using three different viral envelopes. J Gene Med 2002; 4:122-132.
  1. Relander T, Brun A, Olsson K, Pedersen L, and Richter J: Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34+ cells increases gene transfer mediated by GALV pseudotyped vectors. Molecul Therapy 2002; 6(3):400-406.
  1. Rosenberg P, Andersson H, Boman K, Ridderheim M, Sorbe B, Puistola U, and Parö G: Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum. Acta Oncol 2002; 41(5):418-424.
  2. Lao H. Saal, Carl Troein, Johan Vallon-Christersson, Sofia Gruvberger, Åke Borg and Carsten Peterson. BioArray Software Environment: A Platform for Comprehensive Management and Analysis of Microarray Data. Genome Biology 2002 3(8): software0003.1-0003.6
  1. Sjöström J, Collan J, Boguslawski K, Franssila K, Bengtsson N-O, Mjaaland I, Malmström P, Östenstad B, Wist E, Valvere V, Bergh J, Skiöld-Petterson D, Saksela E, and Blomqvist C: C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. Eur J Cancer 2002; 38:535-542.
  1. Sjöström J, Blomqvist C, Boguslawski K, Bengtsson N-O, Mjaaland I, Malmström P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed J,and Saksela E: The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. Clin Cancer Res 2002; 8:811-816.
  1. Tennvall J, Lundell G, Wahlberg P, Bergenfelz A, Grimelius L, Åkerman M, Hjelm Skog AL, and Wallin G: Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002; 86:1848-1853.
  1. Tennvall J, Carlsson J, Lundqvist H, Stigbrand T, och Strand S-E: Radioimmunoterapi av maligna tumörer. Sv Medicin 2002; 72:105-124.
  1. Tynninen O, Sjöström J, von Boguslawski K, Bengtsson NO, Heikkilä R, Malmström P, Østenstad B, Wist E, Valvere V, Saksela E, Paavonen T, and Blomqvist C: Tumour microvessel density as predictor of chemotherapy response in breast cancer patients. Br J Cancer 2002; 86:1905-1908.
  2. Wang Zh, Garkavij M, Tennvall J, and et al: Application of extracorporeal immunoadsorption (ECAT) to reduce circulating blood radioactivity after intraperitoneal administration of 111In-HMFG1-biotin. Cancer 2002; 94:1287-1292.
  1. Åkervall J, Borg Å, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F, and Wennerberg J: Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 2002; 20(1): 45-52.

Submitted

  1. Adeyinka A, Baldetorp B, Mertens F, Olsson H, Johannsson O, Heim S, and Pandis N: Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas. Submitted.
  1. Brun E, Tennvall J, Baldetorp B, Kjellén E, Fallenius G, and Wennerberg J: S-phase and DNA ploidy before and during therapy of HNSCC and associations to FDG-PET. Submitted.
  1. Fredriksson I, Liljegren G, Palm-Sjövall M, Arnesson L-G, Emdin SO, Fornander T, Lindgren A, Nordgren H, Idvall I, Holmqvist M, Holmberg L, and Frisell J: Risk factors for local recurrence after breast-conserving surgery – a large case-control study. Submitted.
  1. Glimelius I, Molin D, Amini R-M, Gustavsson A, Glimelius B, and Enblad G: Bulky disease is the most important prognostic factor in Hodgkin´s lymphoma stage 2B. Submitted.
  1. Högberg T, Fredstorp-Lidebring M, Alm P, Baldetorp B, Larsson G, Ottosen C, Svanberg L, and Lindahl B: Adjuvant radiotherapy is not necessary in the majority of patients with early endometrial cancer: report on a prospective population-based treatment program including primary surgery and postoperative risk assessment by means of DNA-ploidy and histopathology. Submitted.
  1. Jerkeman M, Anderson H, Cavallin-Ståhl E, Dictor M, Hagberg H, Kvalöy S, and Åkerman M: Analysis of bcl-2, p53, Ki-67 and P-glycoprotein as prognostic indicators in aggressive lymphoma. Submitted,
  1. Johansson M, Fredlund J, Baldetorp B, and Oredsson S: The influence of proliferation rate on estimated cell kinetic parameters when using bromodeoxyuridine – flow cytometry technique. Submitted.
  1. Kinhult S, Albertsson M, Eskilsson J, and Cwikiel M: Probucol prevents toxic effects of 5-fluorouracil on vascular endothelium. Submitted to Acta Oncol.
  1. Landgren O, Björkholm M, Bossen Konradsen H, Söderquist M, Nilsson B, Gustavsson A, Axdorf U, Kallin M, and Grimfors G: A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin´s lymphoma. Submitted.
  1. Lilja Å, Smith G, Malmström P, Salford L, Idvall I, and Horstsman V: A psychological ”risk index” in patients with breast cancer. Logistic regression analyses on relations between unfavourable tumour biological prognostic factors and psychological factors. Submitted to Perceptual and Motor Skills.
  1. Luoma M-L, Hakamies-Blomqvist L, Sjöström J, Pluzanska A, Hultborn R, Mouridsen H, Bengtsson N-O, Bergh J, Malmström P-O, Valvere V, Tennvall L, and Blomqvist C: Prognostic value of quality of life scores for time to progression (TTP) and overall survival in advanced breast cancer. Submitted to Eur J Cancer.
  1. Olsson A, Bryngelsson C, Amiri A, Baldetorp B, and Pero R: Anti-proliferative effects of the N-substituted benzamides, metoclopramide and 3-chloro-procainamide: Induction of apoptosis and cell differentiation in HL60 cells. Submitted to Leukemia.
  1. Rudolph P, Kuhling H, Alm P, Fernö M, Baldetorp B, Olsson H, and Parwaresch R: Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. Submitted.
  1. Smith G, Lilja Å, Malmström P, and Salford L: Creativity and breast cancer. A Study of premenopausal women. Submitted to Scand J of Psychology.

In manuscript

Andersson-Engels S, Svanberg K, and Svanberg S: Fluorescence diagnostic imaging. Invited paper in preparation.

Baldetorp B, Bendahl P-O, Fernö M, and Stål O. Group NDFC: Improved DNA flow cytometric S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines. Manuscript.

Bendahl P-O, Fernö M, Johansson M, and Baldetorp B: Flow cytometry DNA analysis in breast cancer – intralaboratory reproducibility. Manuscript.

Eker C, Jaramillo E, Andersson-Engels S, Jonas E, Rubio C, Slezak P, and Svanberg K: Colonic epithelial polyp discrimination in vivo using laser-induced fluorescence. Manuscript.

Gruvberger S, Baldetorp B, Borg Å, and Oredsson S: p53 dependent and independent checkpoint controls are activated in docetaxel-treated breast cancer cells in culture. Manuscript.

Gustafsson U, Troy P, de Weert M, Andersson-Engels S, Pålsson S, Svanberg S, and Svanberg K: Intrinsic fluorescence for in vivo demarcation of cervical precancer. Manuscript.

Hedenfalk I, Hegardt C, Oredsson S, Baldetorp B, Borg Å, and Fadeel B: p53-independent induction of caspase-3-like activity in SK-BR-3 human breast cancer cells. Manuscript.

Håkansson P, Lassen C, Olofsson T, Baldetorp B, Karlsson A, Gullberg U, and Fioretas T: Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Manuscript.

Johansson M, Baldetorp B, and Oredsson S: Estimation of potential doubling time of bromodeoxyuridine-labelled cell populations. Manuscript.

Karu I, Pålsson S, Wang I, af Klinteberg C, Bendsoe N, Andersson-Engels S, Svanberg S, and Svanberg K: Photodynamic therapy using -amino levulinic acid and intensity modulated diode laser light. Manuscript.

Karu I, Wang I, af Klinteberg C, Andersson-Engels S, Svanberg S, and Svanberg K: Evaluation of pain and dysesthesia in connection with diode laser mediated ALA-PDT. Manuscript.

Malmström P, Elston CW, Bendahl P-O, Baldetorp B, Boiesen P, and Fernö M: Histological grade, its three components and flow cytometric S-Phase as prognostic markers in pre- menopausal women with node negative breast cancer. Manuscript.

Pålsson S, Gustafsson L, Stenram U, Soto Thompson M, Johansson T, Stenberg M, Andersson-Engels S, Svanberg K, and Svanberg S: Evaluation of the required absorbed light dose for tumour necrosis due to interstitial photodynamic therapy. Manuscript.

Pålsson S, Stenram U, Jacobson E, McLaughlin B, Andersson-Engels S, Svanberg S, and Svanberg K: Detailed histopathology correlated to fluorescence spectra and imaging in human cervical tissue. Manuscript.

Pålsson S, Gustafsson U, Stenram U, Soto Thompson M, Johansson T, Andersson-Engels S, Svanberg K, and Svanberg S: Estimation of the Protoporphyrin IX photodynamic threshold dose. Manuscript.

Pålsson S, Gustafsson L, Soto Thompson M, Stenberg M, Bendsoe N, Andersson-Engels S, and Svanberg K: Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolevulinic acid. Manuscript.

Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl P-O, Borg Å, Karhu R, Tanner M, Tirkkonen M, and Isola J: Prognostic and clinicopathologic correlations of chromosomal imbalances in breast cancer. A study of 305 tumors by comparative genomic hybridization. Manuscript.

Rydell R, Eker C, Andersson-Engels S, Wahlberg P, and Svanberg K: Fluorescence investigations to identify laryngeal lesions in vivo. Manuscript for Head and Neck.

Soto Thompson M, Johansson T, Pålsson S, Andersson-Engels S, Svanberg S, Bendsoe N, Stenram U, Svanberg K, Spigulis J, Derjabo A, and Kapostins J: Photodynamic therapy of basal cell carcinoma with multi-fibre contact light delivery. Manuscript.

Troy P, Jacobson E, McLaughlin B, Andersson-Engels S, Vaitkuviene A, Pålsson S, Soto Thompson M, Svanberg S, and Svanberg K: Classification of cervical tissue type in vivo by means of fluorescence point-monitoring and hyperspectral imaging. Manuscript.

de Weert M, Troy P, Gustafsson U, Andersson-Engels S, Pålsson S, Svanberg S, and Svanberg K: Quantification of context information in hyperspectral fluorescence imaging of human cervical tissue. Manuscript.

Mars 2003/MF

1